EmailBioscience Initiative
Related Events
| GBC Bioscience Speaker Series, Dr. Judith... Tuesday, March 23, 2010 - 8:30 AM |
|---|
| GBC 5th Annual Maryland Bioscience Awards Thursday, March 25, 2010 - 9:00 AM |
| Bioscience Committee Meeting Thursday, April 29, 2010 - 8:30 AM |
| Bioscience Committee Meeting Thursday, May 6, 2010 - 8:30 AM |
| GBC BioParks Outreach Event Tuesday, May 11, 2010 - 8:30 AM |
| GBC 2010 Annual Meeting Tuesday, May 18, 2010 - 6:30 PM |
Related News
| March 1, 2010 | |
| GBC to celebrate bioscience achievement 5th Annual... | |
The Greater Baltimore Committee's annual breakfast tribute to Maryland's bioscience entrepreneurs is March 25 at the Renaissance Harborplace Hotel in Baltimore. |
|
| January 15, 2010 | |
| Governor O’Malley names Dr. Judith Britz executive... | |
| BALTIMORE, MD (January 15, 2010) – Governor Martin O’Malley today named Dr. Judith A. Britz, a scientist, academician and entrepreneur with more than 25 years in Maryland’s bioscience industry, as Executive Director of the Maryland Biotechnology Center, a part of the Maryland Department of Business and Economic Development. |
|
| January 12, 2010 | |
| Bioscience development, business growth... | |
| Preserving Maryland’s bioscience investment tax credits and other business incentives, support for charter schools and higher education resources, protecting the state’s transportation funding from being used for other purposes, and nurturing the growth of small businesses are among the Greater Baltimore Committee’s priorities for the 2010 session of the Maryland General Assembly, which convenes this week on January 13. |
|
| October 20, 2009 | |
| GBC's Fry: Maryland needs a consensus on business... | |
| MD has many economic development strengths to build on – life sciences, health care, technology, and defense industries; its transportation resources, highly-educated workforce, and quality of life, to mention just a few. |
|
The GBC continues its role as a leader in the Greater Baltimore region for bioscience growth, advocating for biopark funding, stem cell research funding, and tax credits for biotech investment and for research and development.